187 related articles for article (PubMed ID: 33769715)
1. Sphingosine-1-phosphate as a key player of insulin secretion induced by high-density lipoprotein treatment.
Brulhart-Meynet MC; Thomas A; Sidibé J; Visentin F; Dusaulcy R; Schwitzgebel V; Pataky Z; Philippe J; Vuilleumier N; James RW; Gosmain Y; Frias MA
Physiol Rep; 2021 Mar; 9(6):e14786. PubMed ID: 33769715
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells.
Cantrell Stanford J; Morris AJ; Sunkara M; Popa GJ; Larson KL; Özcan S
J Biol Chem; 2012 Apr; 287(16):13457-64. PubMed ID: 22389505
[TBL] [Abstract][Full Text] [Related]
3. Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate.
Kurano M; Hara M; Tsuneyama K; Sakoda H; Shimizu T; Tsukamoto K; Ikeda H; Yatomi Y
Biochim Biophys Acta; 2014 Sep; 1841(9):1217-26. PubMed ID: 24814049
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate counteracts insulin signaling in pancreatic β-cells via the sphingosine 1-phosphate receptor subtype 2.
Japtok L; Schmitz EI; Fayyaz S; Krämer S; Hsu LJ; Kleuser B
FASEB J; 2015 Aug; 29(8):3357-69. PubMed ID: 25911610
[TBL] [Abstract][Full Text] [Related]
5. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
[TBL] [Abstract][Full Text] [Related]
6. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.
Frias MA; Thomas A; Brulhart-Meynet MC; Kövamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
Eur J Clin Invest; 2017 Jan; 47(1):38-43. PubMed ID: 27861771
[TBL] [Abstract][Full Text] [Related]
7. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells.
Rütti S; Ehses JA; Sibler RA; Prazak R; Rohrer L; Georgopoulos S; Meier DT; Niclauss N; Berney T; Donath MY; von Eckardstein A
Endocrinology; 2009 Oct; 150(10):4521-30. PubMed ID: 19628574
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate.
Tong X; Peng H; Liu D; Ji L; Niu C; Ren J; Pan B; Hu J; Zheng L; Huang Y
Cardiovasc Diabetol; 2013 Jan; 12():27. PubMed ID: 23360427
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.
Brinck JW; Thomas A; Brulhart-Meynet MC; Lauer E; Frej C; Dahlbäck B; Stenvinkel P; James RW; Frias MA
Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29178180
[TBL] [Abstract][Full Text] [Related]
10. To Be or Not to Be: The Divergent Action and Metabolism of Sphingosine-1 Phosphate in Pancreatic Beta-Cells in Response to Cytokines and Fatty Acids.
Gurgul-Convey E
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163559
[TBL] [Abstract][Full Text] [Related]
11. The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus.
Tong X; Lv P; Mathew AV; Liu D; Niu C; Wang Y; Ji L; Li J; Fu Z; Pan B; Pennathur S; Zheng L; Huang Y
Cardiovasc Diabetol; 2014 Apr; 13():82. PubMed ID: 24751283
[TBL] [Abstract][Full Text] [Related]
12. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection.
Brinck JW; Thomas A; Lauer E; Jornayvaz FR; Brulhart-Meynet MC; Prost JC; Pataky Z; Löfgren P; Hoffstedt J; Eriksson M; Pramfalk C; Morel S; Kwak BR; van Eck M; James RW; Frias MA
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):817-24. PubMed ID: 26966278
[TBL] [Abstract][Full Text] [Related]
13. Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype.
Fayyaz S; Henkel J; Japtok L; Krämer S; Damm G; Seehofer D; Püschel GP; Kleuser B
Diabetologia; 2014 Feb; 57(2):373-82. PubMed ID: 24292566
[TBL] [Abstract][Full Text] [Related]
14. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
Ruiz M; Okada H; Dahlbäck B
Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.
Malchinkhuu E; Sato K; Muraki T; Ishikawa K; Kuwabara A; Okajima F
Biochem J; 2003 Mar; 370(Pt 3):817-27. PubMed ID: 12470300
[TBL] [Abstract][Full Text] [Related]
16. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium.
Tatematsu S; Francis SA; Natarajan P; Rader DJ; Saghatelian A; Brown JD; Michel T; Plutzky J
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1788-94. PubMed ID: 23723371
[TBL] [Abstract][Full Text] [Related]
17. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
[TBL] [Abstract][Full Text] [Related]
18. HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate.
Sato K; Malchinkhuu E; Horiuchi Y; Mogi C; Tomura H; Tosaka M; Yoshimoto Y; Kuwabara A; Okajima F
Biochem Biophys Res Commun; 2007 Aug; 359(3):649-54. PubMed ID: 17544365
[TBL] [Abstract][Full Text] [Related]
19. Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway.
Izquierdo MC; Shanmugarajah N; Lee SX; Kraakman MJ; Westerterp M; Kitamoto T; Harris M; Cook JR; Gusarova GA; Zhong K; Marbuary E; O-Sullivan I; Rasmus N; Camastra S; Unterman TG; Ferrannini E; Hurwitz BE; Haeusler RA
J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35104242
[TBL] [Abstract][Full Text] [Related]
20. Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases.
Diarte-Añazco EMG; Méndez-Lara KA; Pérez A; Alonso N; Blanco-Vaca F; Julve J
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
